Efficacy News and Research

RSS
CytRx to present new data on molecular chaperone drug discovery technology

CytRx to present new data on molecular chaperone drug discovery technology

Data Safety Monitoring Board supports continuation of trial of Iluvien for diabetic macular edema

Data Safety Monitoring Board supports continuation of trial of Iluvien for diabetic macular edema

Exercise helps pregnant women quit smoking

Exercise helps pregnant women quit smoking

Anthropologists explore cultural dynamics of mental health in native North America:

Anthropologists explore cultural dynamics of mental health in native North America:

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

World Health Organization cautions against claims made by ‘electronic cigarette’ manufacturers

World Health Organization cautions against claims made by ‘electronic cigarette’ manufacturers

Arana updates inflammatory pipeline milestones

Arana updates inflammatory pipeline milestones

Muscle stem cell identity confirmed

Muscle stem cell identity confirmed

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

New drug substantially extends survival in pancreatic cancer

New drug substantially extends survival in pancreatic cancer

Vicor Technologies announces publication of positive results in study conducted in collaboration with U.S. Army

Vicor Technologies announces publication of positive results in study conducted in collaboration with U.S. Army

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Investigational drug shows promise in ovarian cancer

Investigational drug shows promise in ovarian cancer

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Keppra XR approved in the U.S. for partial onset seizures

Keppra XR approved in the U.S. for partial onset seizures

Phase I trial for new tuberculosis vaccine

Phase I trial for new tuberculosis vaccine

New drug promises once-a-day treatment for asthma and hay fever

New drug promises once-a-day treatment for asthma and hay fever

60% of women use herbal products during pregnancy

60% of women use herbal products during pregnancy

Trial demonstrates safety and efficacy of neurally acting anti-migraine agent for treatment of acute migraine

Trial demonstrates safety and efficacy of neurally acting anti-migraine agent for treatment of acute migraine

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.